Score Overview
See the full market ranking โ
Lipocine Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 0.00 to $ 1M and net income went from -$ 20M to -$ 9M. Revenue increased in 1 of those 5 years; net income in 1.
Lipocine Inc currently holds a 5-year HDB Score of 1.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.06 | โ |
1 Year2025-08-12 | $ 2.97 | -30.64% |
5 Years2021-08-12 | $ 25.33 | -91.87% |
10 Years2016-08-12 | $ 76.16 | -97.30% |
All Time2013-10-22 | $ 170.00 | -98.79% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-10-22 |
|---|---|---|---|---|---|
| Price | $ 2.06 | $ 2.97 | $ 25.33 | $ 76.16 | $ 170.00 |
| Return | โ | -30.64% | -91.87% | -97.30% | -98.79% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 11M | $ 23M |
| 2025 | $ 1M | -$ 9M | $ 14M |
| 2024 | $ 11M | $ 8.35K | $ 21M |
| 2023 | -$ 2M | -$ 16M | $ 22M |
| 2022 | $ 500K | -$ 10M | $ 32M |
| 2021 | $ 16M | -$ 634.4K | $ 44M |
| 2020 | $ 0.00 | -$ 20M | $ 19M |
| 2019 | $ 164.99K | -$ 13M | $ 14M |
| 2018 | $ 428.03K | -$ 11M | $ 15M |
| 2017 | $ 0.00 | -$ 20M | $ 21M |
| 2016 | $ 0.00 | -$ 18M | $ 26M |
| 2015 | $ 0.00 | -$ 18M | $ 44M |
| 2014 | $ 0.00 | -$ 20M | $ 27M |
| IPO2013 | $ 0.00 | -$ 10M | $ 45M |
Explore beyond LPCN
You're looking at Lipocine Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
